Maxximilk

Company Overview

Snapshot

Founded in September 2008, Maxximilk operates with 1–10 employees. The company was acquired by Godrej Agrovet in January 2017.

Business overview

Maxximilk is focused on enhancing dairy farm profitability through genetic improvement. The company produces in-vitro, ready-to-transfer pedigree embryos derived from high-yield cows, enabling dairy farmers to rapidly establish herds of champion milk-producing cows. Maxximilk serves the agriculture and food technologies sector, specifically targeting the livestock and dairy industries with its biotechnology and breeding solutions.

Strategic signal

In January 2018, Godrej Agrovet acquired a majority stake in Maxximilk, signaling a strategic move by a major animal feed company to integrate advanced biotechnology into its operations. This acquisition highlights the growing importance of genetic solutions in boosting agricultural productivity and profitability, particularly within the dairy sector, and indicates a market trend towards consolidation and technological adoption in agritech.

Company Intelligence Q&A

What is Maxximilk's primary focus?

Maxximilk focuses on the genetic improvement of dairy herds to boost profitability for dairy farmers, primarily through the transfer of pedigree embryos.

When was Maxximilk founded?

Maxximilk was founded in September 2008.

Where did Maxximilk establish a production facility?

Maxximilk opened a production facility in the Indian state of Maharashtra in 2017, following a partnership with Godrej Agrovet Ltd.

What technology does Maxximilk utilize?

Maxximilk produces in-vitro, ready-to-transfer pedigree embryos from professionally inbred cows to increase milk yields.